baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

UC BON.CAP.CERT. 03/25 SNW/ DE000UG1WV14 /

1/24/2025 9:47:10 PM	Chg.+4.300	Bid9:59:33 PM	Ask9:59:33 PM	Underlying	Strike price	Expiration date	Option type
150.310EUR	+2.95%	150.310 Bid Size: 400	150.500 Ask Size: 400	SANOFI SA INHABER ...	- -	3/28/2025	Call

TeleTrader 1/23 Europe opens mixed with eyes on Davos forum

TeleTrader 12/31/2024 Europe opens year-end session with losses

TeleTrader 11/22/2024 Europe closes higher, FTSE up over 1%

TeleTrader 10/25/2024 Europe closes mixed amid earnings, data

TeleTrader 10/25/2024 Europe lower in premarket as financial results pour in

TeleTrader 10/25/2024 Sanofi's Q3 net sales up by 15.7% to €13.44 billion

TeleTrader 10/21/2024 Sanofi in talks with CD&R for 50% stake in Opella

GlobeNewswire 9/2/2024 Press Release: Tolebrutinib meets primary endpoint in HERCULES phase 3 study, the first and only to ...

GlobeNewswire 8/26/2024 Latest Dupixent® (dupilumab) and Itepekimab Data at ERS Highlight Scientific Innovation and Leadersh...

GlobeNewswire 8/14/2024 Anaptys Announces Pricing of $100 Million Underwritten Registered Direct Offering

GlobeNewswire 8/13/2024 Vigil Neuroscience Reports Second Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire 8/12/2024 MeiraGTx Announces $50 Million Offering of Ordinary Shares led by Sanofi and Reports Second Quarter ...

GlobeNewswire 8/12/2024 MeiraGTx Announces Pricing of Offering of Ordinary Shares Led by Sanofi

GlobeNewswire 8/8/2024 Press Release: Sarclisa induction treatment demonstrated significantly improved progression-free sur...

GlobeNewswire 8/7/2024 Kymera Therapeutics Announces Second Quarter 2024 Financial Results and Provides a Business Update

GlobeNewswire 8/6/2024 Alzheimer's Disease Diagnostics & Therapeutics Market Driven by Use of Biomarkers and Advancing R&D ...

GlobeNewswire 8/5/2024 Fierce Biotech Names Recludix Pharma a “Fierce 15” Biotech Company of 2024

GlobeNewswire 8/2/2024 Madrigal Pharmaceuticals Appoints Shannon Kelley as General Counsel

GlobeNewswire 8/1/2024 Denali Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights

GlobeNewswire 8/1/2024 Regeneron Reports Second Quarter 2024 Financial and Operating Results

GlobeNewswire 7/31/2024 Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Second Quarter 2...

GlobeNewswire 7/25/2024 Press Release: Online availability of Sanofi’s half-year financial report for 2024

TeleTrader 7/25/2024 Europe lower premarket as earnings pour in

TeleTrader 7/25/2024 Sanofi net sales up 7.8% to €10.7B in Q2

GlobeNewswire 7/25/2024 Press Release: Sanofi Q2 - strong performance with 10% sales growth; 2024 guidance upgraded

UC BON.CAP.CERT. 03/25 SNW/ DE000UG1WV14 /

If you wish to receive reply to your feedback, please provide your email address.